Thomas Willgoss is a principal outcomes research scientist at F. Hoffmann-La Roche.
Thomas Willgoss
Research scientist
Roche
From this contributor
How family perspectives could improve clinical trials
Asking people with autism and their families about the challenges they face could help researchers test treatments for the condition.
How family perspectives could improve clinical trials
By
Nicholette Zeliadt
12 December 2017 | 5 min read
Explore more from The Transmitter
Escaping groupthink: What animals’ behavioral quirks reveal about the brain
Neuroscientists have long ignored the variability in animals’ behavioral responses in favor of studying differences across groups. But work on the brain differences that underlie that variability is beginning to pay off.
Escaping groupthink: What animals’ behavioral quirks reveal about the brain
Neuroscientists have long ignored the variability in animals’ behavioral responses in favor of studying differences across groups. But work on the brain differences that underlie that variability is beginning to pay off.
By
Angie Voyles Askham
23 May 2025 | 0 min watch
Immune cells block pain in female mice only
Regulatory T cells in the spinal meninges release endogenous opioids in a sex-specific manner, new work shows.
Immune cells block pain in female mice only
Regulatory T cells in the spinal meninges release endogenous opioids in a sex-specific manner, new work shows.
By
Angie Voyles Askham
22 May 2025 | 5 min read
Exclusive: Layoffs revoked at U.S. National Institute of Neurological Disorders and Stroke
After more than a month of uncertainty, 30 previously purged employees at the institute no longer face termination.
Exclusive: Layoffs revoked at U.S. National Institute of Neurological Disorders and Stroke
After more than a month of uncertainty, 30 previously purged employees at the institute no longer face termination.
By
Angie Voyles Askham, Sydney Wyatt
21 May 2025 | 3 min read